Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 13 | 2023 | 577 | 3.200 |
Why?
|
| Breast Neoplasms | 20 | 2024 | 20822 | 1.180 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2018 | 2015 | 0.960 |
Why?
|
| Receptors, Estrogen | 3 | 2023 | 2187 | 0.650 |
Why?
|
| Receptors, Somatomedin | 1 | 2018 | 57 | 0.630 |
Why?
|
| Mucoproteins | 5 | 2019 | 50 | 0.610 |
Why?
|
| Proteins | 4 | 2017 | 6103 | 0.600 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2023 | 8428 | 0.550 |
Why?
|
| Estradiol | 3 | 2023 | 2020 | 0.550 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2018 | 563 | 0.530 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2021 | 5172 | 0.520 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 934 | 0.510 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 1061 | 0.470 |
Why?
|
| Oncogene Proteins | 5 | 2019 | 749 | 0.440 |
Why?
|
| Inflammatory Breast Neoplasms | 2 | 2024 | 143 | 0.400 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 627 | 0.400 |
Why?
|
| Cell Proliferation | 7 | 2019 | 10481 | 0.360 |
Why?
|
| Cell Movement | 4 | 2019 | 5217 | 0.310 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2016 | 1524 | 0.300 |
Why?
|
| Cell Line, Tumor | 10 | 2023 | 16689 | 0.280 |
Why?
|
| Estrogens | 4 | 2023 | 1566 | 0.270 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2942 | 0.270 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2023 | 170 | 0.220 |
Why?
|
| Signal Transduction | 7 | 2023 | 23403 | 0.210 |
Why?
|
| Paclitaxel | 3 | 2024 | 1708 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2022 | 3557 | 0.190 |
Why?
|
| Mutation | 10 | 2023 | 29786 | 0.180 |
Why?
|
| RNA Interference | 3 | 2018 | 2889 | 0.170 |
Why?
|
| Nitriles | 1 | 2024 | 956 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2018 | 2503 | 0.150 |
Why?
|
| Transfection | 2 | 2016 | 5892 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2018 | 130 | 0.150 |
Why?
|
| Databases, Genetic | 1 | 2023 | 1783 | 0.140 |
Why?
|
| Organoids | 1 | 2022 | 701 | 0.140 |
Why?
|
| Female | 20 | 2024 | 380194 | 0.140 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2018 | 390 | 0.130 |
Why?
|
| Leucine Zippers | 1 | 2015 | 117 | 0.130 |
Why?
|
| Cobalt | 1 | 2015 | 158 | 0.130 |
Why?
|
| Genes, fos | 1 | 2015 | 183 | 0.130 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2017 | 599 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2015 | 286 | 0.120 |
Why?
|
| Carcinoma, Lobular | 1 | 2018 | 484 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 2938 | 0.120 |
Why?
|
| Receptor, erbB-2 | 1 | 2024 | 2416 | 0.120 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 3703 | 0.120 |
Why?
|
| Drug Synergism | 1 | 2018 | 1792 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2024 | 1972 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 21683 | 0.110 |
Why?
|
| Humans | 26 | 2024 | 744343 | 0.110 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 1791 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2022 | 1888 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 905 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2017 | 970 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2024 | 2942 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2505 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1678 | 0.090 |
Why?
|
| Pyrazines | 1 | 2016 | 1230 | 0.090 |
Why?
|
| Imidazoles | 1 | 2016 | 1206 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 3505 | 0.080 |
Why?
|
| Doxorubicin | 1 | 2015 | 2234 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2023 | 12208 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6622 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1526 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2015 | 5179 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 5867 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2015 | 2967 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 2635 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11524 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 3508 | 0.070 |
Why?
|
| Genome, Human | 1 | 2017 | 4420 | 0.060 |
Why?
|
| Protein Binding | 1 | 2016 | 9386 | 0.060 |
Why?
|
| Retinoid X Receptors | 1 | 2023 | 93 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 13695 | 0.060 |
Why?
|
| Tamoxifen | 2 | 2017 | 981 | 0.050 |
Why?
|
| RecQ Helicases | 1 | 2022 | 54 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5535 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 4838 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2021 | 657 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 873 | 0.040 |
Why?
|
| Adherens Junctions | 1 | 2018 | 90 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2022 | 695 | 0.040 |
Why?
|
| Lysine | 1 | 2022 | 1007 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2019 | 4217 | 0.040 |
Why?
|
| Gene Expression | 2 | 2020 | 7799 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2022 | 1586 | 0.040 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2017 | 129 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1878 | 0.040 |
Why?
|
| Cisplatin | 1 | 2022 | 1662 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2716 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 1338 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2018 | 592 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2024 | 13033 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13102 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 40075 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 9239 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3200 | 0.030 |
Why?
|
| RNA | 1 | 2024 | 2749 | 0.030 |
Why?
|
| Cadherins | 1 | 2018 | 907 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2022 | 1058 | 0.030 |
Why?
|
| Mice | 4 | 2023 | 81183 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1341 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2024 | 2728 | 0.030 |
Why?
|
| Dependovirus | 1 | 2017 | 706 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 705 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2018 | 3144 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2022 | 2752 | 0.020 |
Why?
|
| Chromatin | 1 | 2023 | 2934 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1741 | 0.020 |
Why?
|
| Phenotype | 2 | 2018 | 16365 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3689 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.020 |
Why?
|
| Apoptosis | 2 | 2017 | 9727 | 0.020 |
Why?
|
| Stem Cells | 1 | 2023 | 3567 | 0.020 |
Why?
|
| Breast | 1 | 2018 | 1969 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3586 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 3386 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9734 | 0.020 |
Why?
|
| Cell Survival | 1 | 2019 | 5882 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5853 | 0.020 |
Why?
|
| DNA | 1 | 2022 | 7301 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 4186 | 0.020 |
Why?
|
| Animals | 4 | 2023 | 168757 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2023 | 4445 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 6895 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 2038 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4851 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 6114 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 19905 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3597 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5442 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18029 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19229 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9438 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9648 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2024 | 63114 | 0.010 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.010 |
Why?
|
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_